Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.
about
Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virusCurrent and emerging formulation strategies for the effective transdermal delivery of HIV inhibitorsAnti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-NDevelopment of topical microbicides to prevent the sexual transmission of HIVIdentification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide databaseCombination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cellsSyndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpesTargeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides.Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides.Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.Development of dual-acting pyrimidinediones as novel and highly potent topical anti-HIV microbicidesVaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection.Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors.Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention.The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method.Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesSublimable C5A delivery provides sustained and prolonged anti-HIV microbicidal activities.Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection.Guiding the vaginal microbicide trials with biomarkers of inflammation.Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue.C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge.Natural antimicrobial peptides as promising anti-HIV candidates.Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density.Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.Comparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assayEngineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 moleculesVivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infectionBiological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study.Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats.Vaginal drug delivery systems for HIV prevention.
P2860
Q27489390-A54472A2-4055-414C-A17C-3C8BEAF96E9EQ28545757-BDDE0057-8D09-4CA5-8637-DD678CE05E54Q30349885-6E6E5364-515C-44E3-BF5E-052E6A2DFECFQ30357096-91CEEB2E-1E24-4B9D-9B0E-987A29FFEAA2Q33625073-6B672CED-2759-4348-BE27-6182F11F90E5Q33676425-036989D4-91FC-4C25-97ED-F04DEAECB64CQ33770052-33D3BE5F-917B-4A4A-934E-1665BA2135A6Q33826278-063757F6-B892-4B9C-B4EB-152FA2628763Q33930525-D951657B-EE83-431B-A6C3-F141C042153DQ33962742-F4683C72-358F-47E9-B9BD-07D2714FE5F8Q34141544-6C234292-9D06-471A-B401-0ED88A5E9189Q34230399-4527E678-594A-46E2-907E-223F2C2000B5Q34568549-E1A34FAF-4536-4B9D-B442-A921E2862EC8Q34647446-611A3555-658D-408E-8EB8-0D3F8831D713Q34932706-AB1FF358-3A32-4C4D-BA02-6D0AB8C813BAQ35006752-6AB2D985-D8CB-47B0-A13D-34162AEF8AECQ35143890-1D0E892B-5851-4FE5-99CD-7E0C314EAF5BQ35215392-5229EAA0-9D12-4976-9515-E6B561F7DB61Q35364134-0FE7158A-DBE9-4E3C-8A8C-435AC5B77F0CQ35518190-6D454FB2-A62E-446E-97A0-F32B28455FF8Q35689392-7CE0F7F4-70DB-4B91-A846-3B793F3A4CE7Q35701205-C59EDA89-C0F5-40C4-A7B0-7EFBE92B5025Q35917148-601E47BE-1928-40F9-8EAE-9F6E3158120EQ35922038-B63D6887-BEF3-4830-BECD-D08CCD632B86Q35941408-6039A68C-8BEF-4A44-BC7B-9761C7E0A917Q36018914-D56EC4AA-5670-40F8-A953-FEA4AD0A422EQ36284047-394521EB-8402-40FD-AB17-801B5F91B0ADQ36371385-CCC6D400-D577-459D-BF0D-46472C85E56DQ36371505-E07EC75E-C8AD-4F20-B830-6C88ECAD1B5DQ36399466-C1A172B5-07DB-4AEF-80DD-5246A5C03EECQ36438963-4DC35291-E970-40F4-9397-109523CC2845Q36514316-2C125045-F70B-4A4E-8FD8-48E6E7CFA957Q36528448-BCA9B8AE-24FA-409B-AD54-1487FE3E8E96Q36593791-5E1C6DE5-FD60-4B2F-8FB0-F243F54D40EAQ36803970-68B59AD7-7029-411D-AE1C-1BE4DBB93952Q36824239-FF4547A9-B33E-40AB-8372-AA9428AFE315Q37059892-03AF9669-9A2C-4969-A02A-0E27FBB40598Q37107494-9715AC5A-3B53-47BA-81CF-8CC7A5C6ABE3Q37120831-859A3569-B041-4105-8F4C-A8F9CD5A1DDCQ37149107-C3ECEEE3-EB24-4E11-AF20-001A195D4B52
P2860
Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Considerations and development ...... he sexual transmission of HIV.
@ast
Considerations and development ...... he sexual transmission of HIV.
@en
Considerations and development ...... he sexual transmission of HIV.
@nl
type
label
Considerations and development ...... he sexual transmission of HIV.
@ast
Considerations and development ...... he sexual transmission of HIV.
@en
Considerations and development ...... he sexual transmission of HIV.
@nl
prefLabel
Considerations and development ...... he sexual transmission of HIV.
@ast
Considerations and development ...... he sexual transmission of HIV.
@en
Considerations and development ...... he sexual transmission of HIV.
@nl
P2860
P921
P1476
Considerations and development ...... he sexual transmission of HIV.
@en
P2093
Jim A Turpin
P2860
P304
P356
10.1517/13543784.11.8.1077
P407
P577
2002-08-01T00:00:00Z